ASCO 2021: Trial shows benefits of targeted drug against early-stage breast cancer with inherited BRCA mutation 03 Jun 2021
Drug used in breast and ovarian cancer could lead to safer, more effective treatment for neuroblastoma 25 Jun 2020
ASCO 2019: Breast cancer drug effective in 80 per cent of men with BRCA-mutant prostate cancer 05 Jun 2019
Precision drugs could unmask cancers to the immune system and boost the effects of immunotherapy 09 Mar 2019
The ICR responds to the FDA approval of talazoparib for women with BRCA-mutant advanced breast cancer 18 Oct 2018
Scientists uncover DNA ‘shield’ with crucial roles in normal cell division, the immune system and cancer 18 Jul 2018